Showing results (2051-2060 of 2,176) with videos related to

Sort By:
Pageof 218
Science (New York, N.Y.)|February 26, 2005
Cassini Imaging Science: initial results on Phoebe and IapetusC C Porco, E Baker, J Barbara, et al.
Science (New York, N.Y.)|February 26, 2005
Cassini Imaging Science: initial results on Saturn's atmosphereC C Porco, E Baker, J Barbara, et al.
Med (New York, N.Y.)|August 13, 2022
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)Eleftherios Mylonakis, Joseph Lutaakome, Mamta K Jain, et al.
Gut|March 23, 2021
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximabNicholas A Kennedy, James R Goodhand, Claire Bewshea, et al.
Science (New York, N.Y.)|February 26, 2005
Cassini Imaging Science: initial results on Saturn's rings and small satellitesC C Porco, E Baker, J Barbara, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
Critical Care Medicine|May 26, 2026
Prognostic Value of Lung Injury Biomarkers in Patients Hospitalized With COVID-19 Without Respiratory Failure at AdmissionJennifer G Wilson, Greg A Grandits, Birgit Grund, et al.
Gut|June 10, 2020
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panelShahida Din, Alexandra Kent, Richard C Pollok, et al.
The Journal of Infectious Diseases|November 10, 2023
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19Tomas O Jensen, Greg A Grandits, Mamta K Jain, et al.
Nature Communications|March 17, 2022
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumabSimeng Lin, Nicholas A Kennedy, Aamir Saifuddin, et al.
Pageof 218